Scientific Dossiers to Bridge Traditional Knowledge and Modern Regulations

The committee will prepare detailed technical dossiers for each plant, summarising historical uses, phytochemical composition, pharmacological activities and existing clinical data. These dossiers are intended to fill the current evidence gap that hampers regulatory approval processes. The ministry highlighted that the integration of documented traditional benefits with rigorously evaluated modern data will enable more transparent and scientifically justified decisions by regulatory authorities, ultimately fostering confidence among consumers and manufacturers alike.